Type 2 diabetes mellitus Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus
Conditions
Interventions
All participants participants will have access to a mobile application (Droobi Health) which includes a complete diabetes self-management and an educational programme designed to last for 16 weeks. Th
Sponsors
Hamad Bin Khalifa University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The inclusion criteria for the study are individuals living with Diabetes type II, recruited from Al-Ahli Hospital in Qatar for the period of three months. The participants are at least 24 years old, are willing to start changing their lifestyle and adapting new habits and behavior, own a smartphone and know how to use it and have installed Droobi App recommended by the doctor from Google Play or the App Store. 1. Aged 24 years or older 2. Type 2 diabetes 3. Attending Al-Ahli Hospital in Qatar 4. Willing to change their lifestyle and adapt new habits and behaviour 5. Own and are able to use a smartphone 6. Installed the Droobi application, recommended by the doctor, from the Google Play or App Store
Exclusion criteria
Exclusion criteria: N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Impact of the behavioural intervention messages: 1.1. Engagement at an aggregated level will be measured continuously from recruitment until drop-out of the end of the trial. Engagement will be assessed using the following data obtained from Google Analytics analysis of the Droobi database: 1.1.1. User level data (actions done by each user) 1.1.2. Session level data (frequency of individual visits to the application) 1.1.3. Page-view level data (frequency of each individual tab visited in the application) 1.1.4. Event level data (button clicks, message views) 1.1.5. User behaviour data, including how long the user stayed in the application, what is their first and last visited tab in the application and the most common “pathway” which the user goes through in the application 1.2. Engagement on an individual level will be assessed after 16 weeks follow-up using a thematic analysis approach to identify themes and patterns from the recorded interviews. This will be used to device coding themes in order identify issues across participants regarding their readiness for behavioral change. 2. The following clinical variables will be measured as an indicator of the effectiveness of the application: 2.1. HbA1c will be measured as part of routine care using clinical lab results 2.2. Weight gain will be measured as part of routine care by nurses. 2.3. Blood pressure will be measured as part of routine care by nurses. 2.4. Cholesterol will be measured as part of routine care using clinical lab results 2.5. Blood glucose levels will be measured as part of routine care using patient reported outcomes. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Effectiveness of weekly individual messages, assessed through an individual interview with participants at the end of the study (after 16 weeks) 2. Individual perceptions of the quality of the messages, assessed through an individual interview with participants at the end of the study (after 16 weeks) 3. Familiarity and attitude towards messages received, assessed using an interview at the baseline and at the end of the study (after 16 weeks), based on themes in the Theory of Planned Behavior questionnaire | — |
Countries
Qatar
Outcome results
None listed